뉴스

'Modi is a good friend': Trump drops hint on India BTA

Ranveer's 'Don 3' row: Producers Guild to hold fresh talks as FWICE drops non-cooperation order

The Producers Guild of India is mediating the 'Don 3' dispute between Ranveer Singh and Excel Entertainment after FWICE withdrew its non-cooperation directive. The Guild aims for an amicable resolution and clearer industry protocols. Excel Entertainment has cleared pending payments despite reported losses, signaling a potential shift in Bollywood's professional agreements. Read on to know more in detail.

US stocks today: Dow Jones drops over 500 points as Middle East tensions escalate

Wall Street stocks pulled back from ​record highs on Wednesday as flaring tensions in the Middle East and rising crude prices stoked inflation jitters and convinced investors to take some profits.All three major U.S. stock indexes closed in negative territory, dragged lower by financials and tech , with the small-cap Russell 2000 underperforming its larger-cap counterparts.Chips advanced, indicating the artificial intelligence ‌fervor is alive ⁠and well. ⁠Still, most of the Magnificent Seven group of AI-related megacaps were lower."The AI names are trading on their own completely separate world, largely oblivious to macro and geopolitical ​risk, at least within reason," said Ross Mayfield, investment strategy analyst at Baird in Louisville, Kentucky. "And so there's going to be a bid for those ​names, especially on days where everything else looks a little bit less attractive."The S&P Software & Services index declined. It has been battered in recent months by fears of AI disruption.Middle East hostilities intensified as the U.S. and Iran traded a new round of air strikes, ​the latest test of a shaky ceasefire.Oil prices rose, adding to worries that upward ⁠pressure on energy prices ‌could metastasize into broader, systemic inflation."This market continues to demonstrate a tug of war between fundamentals in the ​U.S. economy, which ​are incredibly positive, and concerns that the duration of the conflict in the Middle East will lead to ⁠downside risks," said Bill Northey, senior investment director at U.S. Bank Wealth Management, Billings, Montana. "Our ​framework is centered around the duration of the closure of the Strait of Hormuz as ​the primary input to inflation expectations.""The longer the duration of that closure, the less likely the Federal Reserve will be able to ease in 2026," Northey added.In fact, financial markets are pricing more than a 40% likelihood of a rate hike at the conclusion of the U.S. Federal Reserve's December meeting, up from 9.1% one month ago, according to CME's FedWatch tool.New York Fed President John Williams reiterated his position that the central bank does not need to change interest rates despite upside inflation risks, stating monetary policy is "in the right place."Economic ‌data suggested the labor market was stable, and the services sector continued to expand, but input prices remained elevated and corporate spending plans appeared soft amid rising energy costs and geopolitical uncertainties.The Beige Book, the Fed's ​regional economic survey, showed economic ​activity gathered steam in recent ⁠weeks, employment was little changed, but the fallout from higher energy prices due to the war was pervasive.According to preliminary data, the S&P 500 lost 54.11 points, or 0.74%, to end at 7,555.67 points, while the Nasdaq Composite lost 230.97 points, or 0.85%, to 26,862.93. The Dow ​Jones Industrial Average fell 581.84 points, or 1.13%, to 50,725.95.Among chipmakers, Marvell, Intel, Qualcomm , and Sandisk outperformed.Asset managers dropped after Switzerland's Partners Group capped withdrawals from an $8.6 billion private equity fund. KKR, Blackstone, Blue Owl and Ares Management all lost ground.GameStop advanced after the original meme-stock posted a rise in quarterly revenue and unveiled a $2 billion share buyback program.Elon Musk's SpaceX plans to price its IPO at $135 a share to raise a record $75 billion, a source familiar with the matter told Reuters on Tuesday.Broadcom results were expected shortly.

Trump drops a 10% tariff treat on heavy metal

Gold, silver rates today: Comex gold drops $117/oz; silver tumbles $2.4 as Iran-US tensions trigger oil price rebound

Precious metals plummeted amid escalating Middle East tensions, with gold dropping $117 to $4,476 and silver falling nearly $2.4 to $73.5. The conflict has led to heightened inflation concerns and volatile trading, erasing recent gains and prompting fears of a prolonged standoff.

'Wait For Two Days': Annamalai Drops Big Hint On New Venture Amid Strong Buzz Around BJP Exit

K Annamalai leaves for Delhi amid speculation he may quit BJP, hints at announcement in two days as supporters rally in Coimbatore.

Inox Wind shares crash 8% after Q4 profit drops 45% YoY

Shares of Inox Wind tumbled 8% on Monday after the company reported a consolidated net profit of Rs 105.68 crore for the January-March quarter of FY26, down 45% year-on-year (YoY) from Rs 190 crore in the corresponding quarter last year.Shares of the company crashed to Rs 85.61 apiece on NSE, the lowest level since April 10 this year. The firm’s revenue from operations, meanwhile, fell over 2% YoY to Rs 1,244 crore during the fourth quarter of the financial year, which ended on March 31, 2026, from Rs 1,275 crore in the year-ago period. Total income declined marginally to Rs 1,306 crore, while total expenses increased more than 5% YoY to Rs 1,162 crore during the quarter under review.Inox Wind’s EBITDA declined 6% YoY to Rs 333 crore. For the entire financial year 2026, the company reported a 3% rise in bottom line to Rs 449 crore.JM Financial on Inox WindJM Financial highlighted that the company’s Q4 results were an “all-around” miss on estimates. Its revenue was nearly 25% lower than the brokerage’s estimates. “Since management has not shared details, we estimate execution of 85 MW versus 252 MW QoQ/236 MW YoY. Adjusted PAT moderated to Rs 1.1 billion (-44% YoY, -55% JMFe, -52% consensus). The company has an order book of 3.1GW including 1.5 GW from CESC and 750 MW from group companies. Given the challenges in connectivity, RoW and PPAs, we expect IWL to execute 900 MW/1,100 MW during FY27/28,” it said.The domestic brokerage maintained its ‘Add’ rating on the shares of Inox Wind, but reduced its target price to Rs 101 apiece. This implies an upside potential of nearly 9% from the stock’s previous closing price of Rs 93.02 apiece.Motilal Oswal on Inox WindMotilal Oswal also highlighted that Inox Wind reported a weak set of numbers for Q4. However, it highlighted that the visibility of recurring captive order inflows from Inox Clean, which plans to add 3GW of renewable capacity annually with 20-30% expected to be wind-based, management’s strategy to gradually increase pure equipment supply contracts’ share in the order book from 27% currently to 75% over time, which should improve working capital efficiency and margins, and management’s FY27 revenue growth guidance of 75% YoY with EBITDA margins of 20-22% were the key things it liked about the results.The domestic brokerage lowered its FY27 and FY28 EBITDA estimates by 7% and 6% respectively. It maintained its ‘Buy’ rating on the shares of Inox Wind, with a target price of Rs 110 per share, implying an upside potential of more than 18% from the stock’s previous closing price.Inox Wind share priceInox Wind shares have fallen more than 4% in one week and around 8% in one month to close at Rs 93.02 apiece on Friday. The stock is down more than 24% so far in 2026 and nearly 52% in one year.In the longer term, the shares of the company have delivered returns of more than 169% over three years and 386% over five years. The company currently has a market capitalisation of nearly Rs 9,307 crore. The stock’s P/E ratio stands at nearly 36.(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)

Air passenger traffic drops in April

New Delhi: Domestic air traffic declined 4.2 per cent to little over 1.38 crore in April compared to March amid multiple headwinds, including relatively softer travel demand.The latest data from aviation watchdog DGCA showed that carriers flew more than 1.38 crore passengers in April, 3.47 per cent lower than over 1.43 crore passengers carried in April last year.Also Read: Delhi airport, SpiceJet issue travel advisory: Bad weather likely to affect flight operationsThe decline is 4.2 per cent compared to the traffic of 1.44 crore passengers recorded in March."Passengers carried by domestic airlines during January - April 2026 were 575.49 lakhs as against 575.13 lakhs during the corresponding period of the previous year thereby registering an annual growth of 0.06 per cent and monthly growth of -3.47 per cent," DGCA said in its report for the month of April.Airlines have been facing multiple headwinds, including rising operational costs due to higher fuel prices and relatively slower demand.Amid the challenging scenario, carriers have also temporarily trimmed their network.The Directorate General of Civil Aviation (DGCA) data showed that IndiGo's market share rose to 65 per cent in April from 63.3 per cent in March while that of Air India Group fell to 24.7 per cent from 26.2 per cent.The market share of Akasa Air inched up to 5.8 per cent last from 5.4 per cent in March and that of SpiceJet declined to 3.4 per cent from 3.8 per cent during the same period.Also Read: India's domestic air passenger traffic grows 1.4 pc to 1,677.4 lakh in FY26: ReportIn April, state-owned Alliance Air's share shrunk to 0.3 per cent from 0.6 per cent in March.A total of 3,266 passenger-related complaints were received by scheduled domestic airlines in April and the number of complaints per 10,000 passengers carried for the month stood at 2.36, as per DGCA.In terms of On-Time Performance (OTP) in April, IndiGo topped the list at 88.5 per cent, followed by Air India Group (82.4 per cent), Akasa Air (81.4 per cent), Alliance Air (71.2 per cent) and SpiceJet (31.2 per cent).OTP is computed for ten major airports -- Bangalore, Delhi, Hyderabad, Mumbai, Chennai, Kolkata, Ahmedabad, Cochin, Guwahati and Lucknow.Last month, around 1.12 per cent of the flights were delayed by more than two hours.According to DGCA data, over 1.35 lakh passengers were affected by flight delays and airlines shelled out little over Rs 2.41 crore towards facilitation whereas 77,065 passengers were impacted by flight cancellations and in this regard, carriers paid Rs 2.04 crore towards compensation and facilities.A total of 641 passengers were denied boarding and the airlines shelled out Rs 57.65 lakh for compensation and facilities.

Rain lashes parts of Delhi-NCR; IMD issues yellow alert

Delhi-NCR experienced a welcome respite from the heat as heavy rains brought down temperatures significantly on Saturday. The India Meteorological Department has issued a yellow alert for light rain, thunderstorms, and gusty winds, with further temperature drops anticipated. Air quality has also seen improvement, moving into the satisfactory category.

Gold demand drops 70% after sharp duty hike in India

Kolkata: Gold demand in India slipped about 70% since the government more than doubled import duty from earlier this month, adding to already tepid consumer sentiment amid higher fuel and food prices due to the Iran war.Demand fell to about 7.5 tonnes in the fortnight ended May 27 from around 25 tonnes a year earlier, according to industry estimates. The government increased the import duty on gold to 15% from 6% with effect from May 13."Reports trickling in from jewellers across India shows that there has been a 70% drop in demand after the import duty was hiked," said Surendra Mehta, national secretary of India Bullion & Jewellers Association (IBJA). "The unorganised trade, which comprises 65% of the gold trade, has been worst hit due to the duty hike."Also Read: India's gold import problem may already have a solution at homeJoy Alukkas, chairman of gold jewellery retail chain Joyalukkas, attributed the demand weakness to several factors. "It is not only the high import duty that has dented the demand," he said. "The Prime Minister's appeal to stay away from gold for a year has also impacted consumer sentiment in a big way. At Joyalukkas, we are seeing demand dropping by more than 35%. We are not sure whether it will slip further." 131398034Mehta at IBJA said apart from the gold import duty hike, higher petrol and diesel prices and food items are also weighing on consumer sentiment "as they are not willing to spend on gold now".The effective tax burden on gold, including goods and services tax (GST), has risen to 18.45% from 9.18% after the duty increase. The government raised duties against the backdrop of a weak rupee, elevated crude prices, and geopolitical tensions, while also tightening import rules and capping duty-free imports under the Advance Authorisation Scheme."At present, gold is not in the priority list of consumers," said Mehta. "Moreover, it is now the period of Adhik Maas, when Hindus generally avoid buying anything precious. What is more surprising is that the investment demand for gold has slowed down."Also Read: Kriti Sanon joins GIVA as investor and brand ambassadorThe slump may weigh on investment demand in the second quarter of 2026 after a strong start to the year, said jewellers.Gold Exchange Schemes Take OffIndia's bar and coin demand rose 34% from a year ago to 62.3 tonnes in the March quarter.India consumes about 800-850 tonnes of gold annually. On Friday, gold of 999 purity traded at about ₹1.57 lakh per 10 grams, excluding GST, in Mumbai's spot market.Volumes are weak in south India, traditionally one of the country's biggest gold-consuming markets. Some consumers are also shifting towards lighter and lower-carat jewellery while sales of old gold have risen sharply, according to jewellers. "Consumers are not stretching their budgets," said B Govindan, chairman of Bhima Jewellery. "They are buying whatever fits their budget and therefore choosing lightweight and lower-carat jewellery. On the contrary, there is a huge rush among consumers to sell old gold and take cash back home."Industry executives noted the varied impact of the import duty increase across segments, with many retailers indicating a pause in procurement. "Large chain stores saw a brief period of panic buying after the announcement, driven by expectations of further measures, and while they expect a slowdown in sales, they remain relatively resilient given inventory buffers and continued support from bridal demand," said Kavita Chacko, research head at the World Gold Council (WGC).Mid-sized and regional jewellers are continuing to see demand from affluent customers but are expected to rely more on gold exchange programmes and tighter inventory cycles going forward, she said. "Smaller retailers appear the most vulnerable: already stretched by persistently high prices, they now face added pressure from sales volumes and profit margins," said Chacko.

9 In 10 Births Now In Hospitals, Stunting In Children Drops: NFHS-6

The data shows a healthcare system increasingly capable of preventing maternal death and child malnutrition

Molecule glue drugs shake up cancer care

One of the biggest advances in pancreatic cancer in decades came out of a crazy idea born in a Harvard University lab.Chemical biologist Gregory Verdine believed you could fight disease-causing proteins hidden inside cells by chemically gluing them to something else in the body and smothering them."Everybody told us this is crazy, that it would never work," he recalls.Revolution Medicines, which bought one of Verdine's companies in 2018, recently announced that one of its drugs doubled the typical survival time for patients with aggressive forms of the disease, from 6.7 months to 13.2 months. The full results from the company's final-stage trial are expected to be the star of the show at the annual confab of cancer doctors in Chicago this weekend.Spurred by the success of RevMed, numerous companies are now racing to develop similar drugs, dubbed "molecular glues", which can be used to treat a variety of ailments. And investors and pharmaceutical companies with deep pockets are chasing after them, creating one of the hottest corners of dealmaking in the industry.Also read | India's out-of-pocket healthcare spending drops significantly, govt data showsIt's not unusual for exciting new drugs to spark surges in stock prices and dealmaking frenzy. But molecular glue is a particularly complicated science, and the startups pursuing technologies similar to RevMed are mostly in early stages of testing. Their medicines won't be ready for years, if ever.That hasn't stopped big drugmakers such as Novartis, Roche Holding and Eli Lilly from inking research pacts with glue developers that could pay out billions of dollars in milestones.The boom has been especially lucrative for Monte Rosa Therapeutics. Over the past three years, the Boston-based biotech firm has signed three agreements that could be worth over $10 billion to develop molecular glue drugs with both Novartis and Roche.The company, which trades under the stock ticker GLUE, has seen its shares surge nearly 400% over the past year. It's preparing to start mid-stage trials for multiple drugs by the end of this year."The run-up in the share price is justified based on what we've seen so far," says Robert Driscoll, an analyst at Wedbush. Gains are "due to the success of their drugs rather than kind of exuberance around the glue technology as a whole", he says.Science of GlueMolecular glues work in a fundamentally different way from other oral medicines. Most pills - like Prozac for depression or Lipitor for cholesterol - are tiny chemicals that squeeze into a pocket inside a much larger protein to gum up its functioning. But many proteins have few obvious pockets, including key cancer-causing proteins.In fact, about 80% of all proteins in the body are what scientists refer to as "undruggable", meaning they can't be targeted with traditional drug technologies.RevMed's daraxonrasib cleverly circumvents this problem by acting as a molecular stickum. Once inside the body it binds to a healthy protein on one side and then draws in the bad protein to stick to the other side. The healthy protein helps block the bad protein and turn off its signalling.Competitors Line UpMultiple companies are chasing RevMed's lead in pancreatic cancer despite the long odds. San Diego-based Erasca is in early stages of testing a drug it says is more potent than daraxonrasib. Japanese drugmaker Astellas Pharma has begun final-stage trials of a degrader that may help a subset of pancreatic and lung cancer patients.Molecular glues are also being developed as alternatives to injectable drugs used to treat autoimmune and skin disorders. Shares of Kymera Therapeutics have soared more than 180% in the past year thanks to promising early trial results. The company is developing a once-daily pill it hopes will one day compete with Sanofi and Regeneron Pharmaceuticals' Dupixent, one of the world's bestselling drugs."The technology allows you to go after things that would have been almost impossible" to do previously with pills, says Nello Mainolfi, Kymera's founder and CEO.With few effective options for pancreatic cancer, analysts expect RevMed's daraxonrasib to become an enormous bestseller for the company.Prospects for daraxonrasib and speculation about a potential takeout deal have inflated RevMed's market cap to nearly $33 billion. That's a lofty figure for a drugmaker with no approved medicines.The company is preparing to file for US approval soon, and the FDA has promised to give the drug an ultrafast review. It's projected to reach $7 billion in sales a year by 2032, according to the average of estimates compiled by Bloomberg.

“Right Time for CM Change” – Congress' Ajay Dharam Singh Drops Big Hint on Karnataka Cabinet

| This is the right time for CM change. This time they will consider a lot of youngsters and cabinet will be a mix of experience and new blood. I think I will be made a minister this time: @ajaydharamsingh, Congress -newsn18oc_politicsNews18 Mobile App - https://onelink.to/desc-youtube

Oil prices: Crude drops below $95 amid US-Iran ceasefire extension speculation

Oil prices dipped Friday as traders reacted to reports of a potential 60-day extension to a US-Iran ceasefire, which could ease restrictions on the Strait of Hormuz. While US Vice President Vance indicated a deal is close, sticking points remain, and renewed tensions on the ground underscore the ceasefire's fragility.

Delhi-NCR Temperature Drops Nearly 10°C After Rain: How Long Will Relief Continue?

After Thursday’s rainfall, temperatures in Delhi-NCR are expected to remain relatively moderate, with the mercury likely to stay between 34°C and 35°C till Sunday.

A.P. TDP chief gives up Y-category security convoy after PM’s fuel appeal

Telugu Desam Party State chief Palla Srinivasa Rao returns bullet-proof vehicle, drops green-channel movement, says public representatives must lead by example

Adani Group Stocks Rally Day After US Drops All Charges Against Gautam Adani

The Adani Group has consistently rejected the allegations as meritless.